StudentShare
Contact Us
Sign In / Sign Up for FREE
Search
Go to advanced search...
Free

Analysis of the Impact of the Macro Environment on the Pharmaceutical Industry - Assignment Example

Cite this document
Summary
This essay provides an overview of how the external environment has affected the development of the pharmaceutical industry in the early 21st century, underpinned with appropriate theory. It considers what constitutes the external environment and analyses the pharma industry using global tectonics…
Download full paper File format: .doc, available for editing
GRAB THE BEST PAPER93.1% of users find it useful
Analysis of the Impact of the Macro Environment on the Pharmaceutical Industry
Read Text Preview

Extract of sample "Analysis of the Impact of the Macro Environment on the Pharmaceutical Industry"

Analysis of the Impact of the Macro Environment on the Pharmaceutical Industry This essay provides a brief overview of how the external environment has affected the development of the pharmaceutical industry in the early 21st century, underpinned with appropriate theory. It begins by considering what constitutes the external environment, then analyses the pharmaceutical industry using global tectonics (de Kluyver and Pearce 2009) to identify relevant issues and relate these to the case study to assess their impact. A conclusion is then drawn from the analysis. (73 words) The External Environment Johnson et al (2008, p.54) define the external environment as “broad environmental factors that impact to a greater or lesser extent on almost all organisations” and identifies the PESTEL (Political, Economic, Social, Technological, Environmental and Legal) framework as a tool for its analysis. “Changing market forces and growing public expectations” (Wilson, 2000, p.12) have added business ethics to the mix. The external environment includes both competitive and industry factors. Interestingly, Johnson et al (2008) expect all competitors to be within the same industry, when this might not be the case. Equally, not all industry players compete in the same markets. Thus the diagram reflects the less-than-tidy reality of players who exist within any industry, yet compete across industry boundaries and within different competitive environments, falling outside the rational approach to strategy. The underlying factor is the organisation’s ability to control the external environment. An organisation has influence in the competitive arena, using marketing tools to influence others, but no control over the macro (PESTEL/STEEPLE) factors and must react to changes when they happen. Strategy traditionally focused on rational future planning, what Whittington (2001) calls “classical” and Mintzberg and Waters (1985), “deliberate” strategy. But the effects of changing macro factors fall within Whittington’s (2001) “systemic” and Mintzberg and Waters’ (1985) “emergent” strategy as such changes cannot be predicted and consequently would not feature in any strategic planning. (229 words) Global Tectonics In analysing the external environment, de Kluyver and Pearce (2009 p.59) use global tectonics, defined as “the process by which developing trends in technology, nature and society” change the external environment. Three tectonics are identified: Environmental tectonics, which arise from “the interactions between people and their environment.....[which] impact resource management, health and the quality of life” (ibid) Technological tectonics, which consider the advances made in different technologies and the spread of information, and Societal tectonics, which reflect changes in “governance and political and cultural values” (ibid). The tectonics provide a relevant and appropriate framework for the analysis that reflects the reality of a business environment where influences cannot be neatly categorised under PESTEL/STEEPLE headings. (119 words) Environmental Tectonics Within environmental tectonics, the pharmaceutical industry is affected by the impact of people and environmental interactions relating to health and the quality of life. These provide both opportunities and problems. An ageing world population provides an opportunity for drugs to remedy age-related diseases, however, increasing customer expectations (Johnson et al, 2008, p.610) mean the pharmaceutical industry must deliver high quality, extremely effective solutions to meet customer demands within cost constraints imposed by governments. Expanding operations to the developing world also provides opportunities and problems. The pharmaceutical industry can help alleviate untreated. However, unlike their position in the developed world, they do not have patent protection and a relatively open market (ibid, pp.613-614) for cost recovery, thus negotiate with governments to get the best deal possible. The spread of infectious diseases also represents an opportunity to provide new drugs and healthcare infrastructure, but new diseases, such as HIV/AIDS, are more difficult to treat, with increased costs associated with research and development that are unlikely to be recovered, even with patent protection (ibid, p.614). There are also issues relating to ethics (see Societal Tectonics, below). (185 words) Technological Tectonics Advances in both biotechnology and nanotechnology provide opportunities to develop different drugs for medical use, expanding into agricultural use. Nanotechnology might well replace drug and surgery use with bespoke solutions for individuals, although this is some way off in the future. These will affect how the pharmaceutical industry develops drugs and alternatives, requiring new processes and potentially large capital investment in new facilities to take advantage of the new technologies. It has resulted in many small bio-tech firms being taken over by the larger pharmaceutical companies to facilitate the transition to different technology (ibid, p.612). The advances made with information systems are a double-edged sword. A knowledge economy puts scientific knowledge within the pharmaceutical industry but such knowledge is contained within the heads of scientists, rather than recorded in company processes and procedures. Loss of scientists, increasingly possible with increased competition and an ageing workforce, would result in major problems for R&D teams. The pharmaceutical industry appears not to have done anything about this potential problem. (168 words) Societal Tectonics Between 2000-2006, many countries moved from state provision to individual provision, relying on markets to supply what was required. Yet state control of pharmaceutical companies increased following scandals surrounding non-disclosure of clinical trials data that caused patient deaths (BBC News, 2004 and Batty et al 2008). Such ethical problems run counter to increasing customer expectations (Johnson et al, 2008, p.610). A further ethical dilemma arose in connection with the supply of drugs to the developing world, who were challenged by multiple drug manufacturers when they attempted to create generic versions of extremely expensive proprietary medicines (ibid, p616). The situation was resolved by an agreement reached to supply developing nations at reduced prices, but the pharmaceutical industry did not look good as a result. Such ethical issues are likely to affect recruitment of younger workers, who increasingly consider the ethical position of potential employers. The pharmaceutical industry may find future generations of scientists no longer wish to work for them. Governance reforms, including cost controls and increasing international collaboration regarding drug prices (ibid, p.610), serve to restrict the actions of the pharmaceutical industry further. (185 words) Conclusion The pharmaceutical industry cannot escape the effects of changes in the external environment. Because it operates around the world, different changes will occur in different markets and countries, requiring different responses just to remain in business. No industry operates in a vacuum. Operations take place within different contexts, requiring context-specific strategies that give rise to an apparently paradoxical overall corporate strategy for organisations operating within the pharmaceutical industry. This is the “unusual picture” described by Johnson et al (2008, p.608) within the case study. (85 words) (Total 1,044 words) References Batty, D., Hodgson, M. and Watt, N. (2008) ‘Drug companies must reveal more data after Seroxat results withheld’, The Guardian, 6th March available online at http://www.guardian.co.uk/society/2008/mar/06/health.health [accessed 8th December 2010] BBC News (2004) ‘Negative drug research ‘withheld’’, 23rd April, available online at http://news.bbc.co.uk/1/hi/health/3652185.stm [accessed 8th December 2010] de Kluyver, C. A. and Pearce (II), J. A. (2009) Strategy: A View from the Top (An Executive Perspective) (3rd edn.) Pearson, London Johnson, G., Scholes, K. and Whittington, R. (2008) Exploring Corporate Strategy: Text and Cases (8th edn.) FT Prentice Hall, Harlow Mintzberg, H. and Waters, J. A. (1985) ‘Of Strategies, Deliberate and Emergent’ in Strategic Management Journal Vol. 6 pp.257-272 Whittington, R. (2000) What is Strategy and Does it Matter? (2nd edn.) Thomson, London Wilson, I. (2000) ‘The New Rules: Ethics, Social Responsibility and Strategy’ in Strategy & Leadership Vol. 28 pp.12-16 Read More
Cite this document
  • APA
  • MLA
  • CHICAGO
(“Analysis of the Impact of the Macro Environment on the Pharmaceutical Assignment”, n.d.)
Analysis of the Impact of the Macro Environment on the Pharmaceutical Assignment. Retrieved from https://studentshare.org/business/1574147-using-appropriate-theory-critically-analyse-the-macro-environmental-factors-that-have-influenced-the-development-of-the-global-pharmaceutical-industry-during-the-period-covered-by-the-case
(Analysis of the Impact of the Macro Environment on the Pharmaceutical Assignment)
Analysis of the Impact of the Macro Environment on the Pharmaceutical Assignment. https://studentshare.org/business/1574147-using-appropriate-theory-critically-analyse-the-macro-environmental-factors-that-have-influenced-the-development-of-the-global-pharmaceutical-industry-during-the-period-covered-by-the-case.
“Analysis of the Impact of the Macro Environment on the Pharmaceutical Assignment”, n.d. https://studentshare.org/business/1574147-using-appropriate-theory-critically-analyse-the-macro-environmental-factors-that-have-influenced-the-development-of-the-global-pharmaceutical-industry-during-the-period-covered-by-the-case.
  • Cited: 3 times

CHECK THESE SAMPLES OF Analysis of the Impact of the Macro Environment on the Pharmaceutical Industry

How Is the Marketing Concept and Its Implementation Responding To Developments in the Macroenvironment

The business organizations generally deal with certain business environmental factors, out of which the macro environmental factors play a vital part of the organizations.... The aspect of marketing environment is fundamentally viewed as a crucial constituent of a business environment that generally influences the capabilities of a particular company for the purpose of promoting as well as performing proficient business operations in the financial market....
13 Pages (3250 words) Essay

Globalization Strategy of an Indian Pharmaceutical Company

US pharmaceutical industry has discovered almost 370 different drugs in last decade.... the pharmaceutical market is highly competitive as a number of established pharmaceutical companies operate in USA.... The study will discuss the effect of each factor in USA market with respect to the pharmaceutical companies.... Purpose of the Report The report will principally analyze the macro and micro environments of USA with the intention of finding business opportunities....
10 Pages (2500 words) Essay

Multi-national organization that is an ideal candidate for acquisition

According to Magidibe (2011) reported that the pharmaceutical industry is also risky because to develop a drug requires huge investments and out of the many thousands of discovered compounds.... the pharmaceutical industry has many challenges if you want to establish the organization globally.... With my pharmaceutical company investing in a nation that we were not aware of the pharmaceutical industry, therefore the need to align with AstraZeneca....
4 Pages (1000 words) Research Paper

Marketing Plan - XYZ

In the macro environment a look at the level of the political, economic and regulatory forces on a National level will be included.... hellip; Within the construct of the macro, meso and micro environments will be a situational analysis which presents the context of this business and a SWOT analysis that assesses the business to date and its prospects going forward.... This report will introduce Practice XYZ and how this practice fits into the scheme of private specialist practices and the marketing environment....
27 Pages (6750 words) Essay

An Evaluation and Analysis of Risk Management: UK Pharmacy Industry

?? (The influence of the pharmaceutical industry, 2005, p.... As a result, risk management plays an integral role in assuring the quality of the pharmaceutical products and services.... Quality assurance (QA) is highly important in the pharmaceutical sector as it helps... In recent years due to financial crisis in this industry also have some effect budgeting problems.... Medicines cost the NHS in England over £7 billion every year, The industry which has produced these drugs has understandably been described as “world class and a jewel in the crown of the UK economy”....
11 Pages (2750 words) Essay

Economies, Markets and Strategic Decisions

Qatar has historically relied on state level revenues from its vast hydrocarbon industry, however this has left growth rates stagnant in… In Qatar, science and engineering industries are growing at faster rates than that of the university and educational sector needed to support the labour for it (SESD 2004).... However, since Qatar has only recently expanded its macro-level objectives outside of hydrocarbons, there are still ample opportunities for telecom exports, information technology, agri-foods, education, health, construction and financial services (Spence)....
12 Pages (3000 words) Research Paper

Strategic Analysis of Pharmaceutical Sector Company - GlaxoSmithKline

the pharmaceutical industry has become tougher and more competitive due to tighter regulations, raft of patent expiries and technological advancements.... the pharmaceutical industry has generally performed well and managed to preserve various incentives to invention.... The main economic regulation, however, comes through the pharmaceutical Price Regulation Scheme (PPRS), which limits the rate of returns associated with medicine sales.... Climate has emerged to be a key issue in the industry, with stakeholders striving to come up with products that do not have detrimental impacts on health and the environment....
12 Pages (3000 words) Essay

The Global Pharmaceutical Industry

This paper demonstrates Lonza's success, one of the world's leading suppliers to the pharmaceutical, healthcare, and life science industries.... the pharmaceutical companies have come under pressure due to the cost-cutting measures being applied in the seven major markets (Bionaturis, 2008).... Apart from the credit crunch, novel products have entered the market contributing to the declining return on investment in the pharmaceutical sector.... Health care costs and the quality of patient care are the two primary concerns in the industry today....
10 Pages (2500 words) Term Paper
sponsored ads
We use cookies to create the best experience for you. Keep on browsing if you are OK with that, or find out how to manage cookies.
Contact Us